Canada to get up to 1.1 m more doses by March through global vaccine alliance

news-update

Canada could get more than one million additional doses of COVID-19 vaccine by the end of March through a global vaccine sharing initiative known as COVAX.
    
But as with most things COVID-19, vaccine-related deliveries are mired in the uncertainty of regulatory reviews and potential production delays.
    
The COVAX Facility, co-ordinated by the World Health Organization and Gavi, The Vaccine Alliance, pools funds from wealthier countries to buy vaccines for themselves and for 92 low- and middle-income nations that can't afford to buy on their own.
    
Canada contributed $440 million to COVAX in September, half of which secured doses for Canada directly, from about nine vaccines that are participating in the program.
    
The other half goes into a pooled fund to buy doses for 20 per cent of the people in 92 low- and middle-income countries.
    
Procurement Minister Anita Anand tells The Canadian Press that up to 1.1 million doses of AstraZeneca's vaccine could arrive through COVAX by the end of March and up to 3.2 million total by the end of June.